US Patent 9669160 Temporary suspension for closed-loop medicament therapy
Patent 9669160 was granted and assigned to Tandem Diabetes Care on June, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 30, 2015
Date of Patent
June 6, 2017
Patent Applicant
Patent Application Number
14813699
Patent Inventor Names
Paul Harris
0
David Berger
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9669160 Temporary suspension for closed-loop medicament therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
